<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010060135">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Khamduang, W.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Ngo-Giang-Huong, Nicole</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Gaudy-Graffin, C.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Jourdain, Gonzague</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Suwankornsakul, W.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Jarupanich, T.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Chalermpolprapa, V.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Nanta, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Puarattana-aroonkorn, N.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Tonmat, S.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Lallemant, Marc</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Goudeau, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Sirirungsi, W.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Prevalence, risk factors, and impact of isolated antibody to hepatitis b core antigen and occult hepatitis b virus infection in hiv-1-infected pregnant women</title>
        <secondary-title>Clinical Infectious Diseases</secondary-title>
      </titles>
      <pages>1704-1712</pages>
      <keywords>
        <keyword>HIV-1-infected pregnant women</keyword>
        <keyword>isolated anti-HBc</keyword>
        <keyword>occult HBV infection</keyword>
        <keyword>perinatal transmission</keyword>
        <keyword>THAILANDE</keyword>
      </keywords>
      <dates>
        <year>2013</year>
      </dates>
      <call-num>fdi:010060135</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Clinical Infectious Diseases</full-title>
      </periodical>
      <isbn>1058-4838</isbn>
      <accession-num>ISI:000319466600004</accession-num>
      <number>12</number>
      <electronic-resource-num>10.1093/cid/cit166</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010060135</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/depot/2013-10-28/010060135.pdf</url>
        </pdf-urls>
      </urls>
      <volume>56</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Background. Prevalence and risk factors for isolated antibody to hepatitis B core antigen (anti-HBc) and occult hepatitis B virus (HBV) infection are not well known in human immunodeficiency virus type 1 (HIV-1)-infected pregnant women. It is unclear if women with occult infections are at risk of transmitting HBV to their infants. Methods. HIV-1-infected and HBV surface antigen (HBsAg)-negative pregnant women were tested for anti-body to HBsAg (anti-HBs) and anti-HBc using enzyme immunoassay. Women with isolated anti-HBc were assessed for occult HBV infection, defined as HBV DNA levels &gt;15 IU/mL, using the Abbott RealTime HBV DNA assay. Infants born to women with isolated anti-HBc and detectable HBV DNA were tested at 4 months of age for HBV DNA. Logistic regression analysis was used to identify factors associated with isolated anti-HBc and occult HBV infection. Results. Among 1812 HIV-infected pregnant women, 1682 were HBsAg negative. Fourteen percent (95% confidence interval [CI], 12%-15%) of HBsAg-negative women had an isolated anti-HBc that was independently associated with low CD4 count, age &gt;35 years, birth in northern Thailand, and positive anti-hepatitis C virus serology. Occult HBV infection was identified in 24% (95% CI, 18%-30%) of women with isolated anti-HBc, representing 2.6% (95% CI, 1.9%-3.5%) of HIV-1-infected pregnant women, and was inversely associated with HIV RNA levels. None of the women with isolated anti-HBc and occult HBV infection transmitted HBV to their infants. Conclusions. HIV-1-infected pregnant women with isolated anti-HBc and occult HBV infection have very low HBV DNA levels and are thus at very low risk to transmit HBV to their infants.</abstract>
      <custom6>052 ; 050</custom6>
      <custom1>UR174</custom1>
      <custom7>Thaïlande</custom7>
    </record>
  </records>
</xml>
